Clinical Trial Update: Tocotrienols in Parkinson's Disease (PD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tocotrienols for Parkinson disease is currently active but not recruiting, sponsored by the National Neuroscience Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Tocotrienols (tocotrienols)

Snippet

Sponsor: National Neuroscience Institute | Conditions: Neuro-Degenerative Disease, Parkinson Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING